{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:46:53Z","timestamp":1788839213312,"version":"build-2803163510"},"reference-count":88,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Drug Delivery"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1080\/10717544.2019.1587043","type":"journal-article","created":{"date-parts":[[2019,3,24]],"date-time":"2019-03-24T11:43:13Z","timestamp":1553427793000},"page":"384-392","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":107,"title":["A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience"],"prefix":"10.1080","volume":"26","author":[{"given":"Bart J. F.","family":"van den Bemt","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Sint Maartenskliniek","place":["Ubbergen, The Netherlands"]},{"name":"Department of Pharmacy, Radboud University Medical Centre","place":["Nijmegen, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Gettings","sequence":"additional","affiliation":[{"name":"Insight - Cell to Psychology","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Doma\u0144ska","sequence":"additional","affiliation":[{"name":"UCB Pharma","place":["Slough, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bruggraber","sequence":"additional","affiliation":[{"name":"UCB Pharma","place":["Slough, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Mountian","sequence":"additional","affiliation":[{"name":"UCB Pharma","place":["Brussels, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars E.","family":"Kristensen","sequence":"additional","affiliation":[{"name":"The Parker Institute, Copenhagen University Hospital","place":["Bispebjerg and Frederiksberg, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,3,24]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau2277"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-018-0109-3"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e3182a11958"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu358"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2013.795942"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.2223\/JPED.2227"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-017-4800-y"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2017.1251291"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/2047487317750913"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.2165\/00137696-200301030-00005"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei114"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.08.1095"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0645-1"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2016.1256283"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.2165\/00115677-200816010-00003"},{"key":"e_1_3_3_17_1","unstructured":"EMA (2018). Summary of product characteristics: benepali. https:\/\/www.ema.europa.eu\/documents\/product-information\/benepali-epar-product-information_en.pdf"},{"key":"e_1_3_3_18_1","unstructured":"FDA (2016a). Applying human factors and usability engineering to medical devices: guidance for industry and Food and Drug Administration staff. https:\/\/www.fda.gov\/downloads\/MedicalDevices\/\u2026\/UCM259760.pdf."},{"key":"e_1_3_3_19_1","unstructured":"FDA (2016b). Human factors studies and related clinical study considerations in combination product design and development: draft guidance for industry and FDA staff. https:\/\/www.fda.gov\/downloads\/RegulatoryInformation\/Guidances\/UCM484345.pdf."},{"key":"e_1_3_3_20_1","first-page":"258","article-title":"Disease burden and treatment adherence in psoriasis patients","volume":"92","author":"Feldman SR","year":"2013","unstructured":"Feldman SR. (2013). Disease burden and treatment adherence in psoriasis patients. Cutis 92:258\u201363.","journal-title":"Cutis"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i27.4344"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-016-0598-4"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04622.x"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.019422"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1258\/jrsm.2012.120036"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000117"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0000000000000376"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206593"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S101175"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2017-0146"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23768"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-015-0140-1"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev113"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2004.00269.x"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep170"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4967(24)43387-6"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/msc.141"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080633"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/08870449908407311"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2017-000101"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/150658"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-018-0306-8"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1184"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-9-2"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.10.006"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1586\/17434440.4.2.109"},{"key":"e_1_3_3_47_1","first-page":"195","article-title":"Usability of devices for self-injection: results of a formative study on a new disposable pen injector","volume":"7","author":"Lange J","year":"2014","unstructured":"Lange J, Richard P, Bradley N. (2014). Usability of devices for self-injection: results of a formative study on a new disposable pen injector. Med Devices (Auckl) 7:195\u2013203.","journal-title":"Med Devices (Auckl)"},{"key":"e_1_3_3_48_1","first-page":"255","article-title":"Usability of a new disposable autoinjector platform device: results of a formative study conducted with a broad user population","volume":"8","author":"Lange J","year":"2015","unstructured":"Lange J, Richard P, Bradley N. (2015). Usability of a new disposable autoinjector platform device: results of a formative study conducted with a broad user population. Med Devices (Auckl) 8:255\u201364.","journal-title":"Med Devices (Auckl)"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10558-w"},{"key":"e_1_3_3_50_1","first-page":"559","article-title":"Adherence to biologic therapies and associated factors in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis: a systematic literature review","volume":"33","author":"Lopez-Gonzalez R","year":"2015","unstructured":"Lopez-Gonzalez R, Leon L, Loza E, et\u00a0al. (2015). Adherence to biologic therapies and associated factors in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis: a systematic literature review. Clin Exp Rheumatol 33:559\u201369.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40267-017-0446-2"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.4103\/2230-973X.93004"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czn047"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0759-0"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1177\/1074248412442001"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.02.001"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1706-x"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev306"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60524-9"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2015.07.010"},{"key":"e_1_3_3_61_1","volume-title":"Human factors and usability engineering \u2013 guidance for medical devices including drug-device combination products","author":"MHRA,","year":"2017","unstructured":"MHRA, (2017). Human factors and usability engineering \u2013 guidance for medical devices including drug-device combination products. London, UK: MHRA."},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0441-3"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev105"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1109\/TITB.2009.2039711"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-012-1034-4"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186458"},{"key":"e_1_3_3_67_1","first-page":"5591","article-title":"Medical device development","volume":"2009","author":"Panescu D","year":"2009","unstructured":"Panescu D. (2009). Medical device development. Conf Proc IEEE Eng Med Biol Soc 2009:5591\u20134.","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0801-4"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.12.001"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1177\/193229681300700307"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12160-013-9579-2"},{"key":"e_1_3_3_72_1","first-page":"397","article-title":"What are the reasons for patient preference? A comparison between oral and subcutaneous administration","volume":"150","author":"Quante M","year":"2012","unstructured":"Quante M, Thate-Waschke I, Schofer M. (2012). What are the reasons for patient preference? A comparison between oral and subcutaneous administration. Z Orthop Unfall 150:397\u2013403.","journal-title":"Z Orthop Unfall"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.3.337"},{"key":"e_1_3_3_74_1","doi-asserted-by":"crossref","unstructured":"Rubin DT Mittal M Davis M et al. (2017). Impact of a patient support program on patient adherence to adalimumab and direct medical costs in Crohn's disease ulcerative colitis rheumatoid athritis psoriasis psoriatic arthritis and ankylosing spondylitis. J Manag Care Spec Pharm 23:859\u201367.","DOI":"10.18553\/jmcp.2017.16272"},{"key":"e_1_3_3_75_1","first-page":"e22","article-title":"Effect of medication dosing frequency on adherence in chronic diseases","volume":"15","author":"Saini SD","year":"2009","unstructured":"Saini SD, Schoenfeld P, Kaulback K, et\u00a0al. (2009). Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care 15:e22\u201333.","journal-title":"Am J Manag Care"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(03)00063-7"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0286-9"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-017-0080-4"},{"key":"e_1_3_3_79_1","first-page":"201","article-title":"Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis","volume":"33","author":"Schulze-Koops H","year":"2015","unstructured":"Schulze-Koops H, Giacomelli R, Samborski W, et\u00a0al. (2015). Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis. Clin Exp Rheumatol 33:201\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar996"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apergo.2011.05.014"},{"key":"e_1_3_3_82_1","doi-asserted-by":"crossref","unstructured":"Sivamani RK Goodarzi H Garcia MS et al. (2013). Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring. Clinic Rev Allergy Immunol 44:121\u201340.","DOI":"10.1007\/s12016-012-8301-7"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-13-467"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2015.1108961"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0672"},{"key":"e_1_3_3_86_1","article-title":"Impact of patient support program utilization on patient activation measure scores among patients with rheumatoid arthritis [abstract]","volume":"69","author":"Van den Bosch F","year":"2017","unstructured":"Van den Bosch F, Wassenberg S, \u00d6st\u00f6r A, et al. (2017). Impact of patient support program utilization on patient activation measure scores among patients with rheumatoid arthritis [abstract]. Arthritis Rheumatol 69. https:\/\/acrabstracts.org\/abstract\/impact-of-patient-support-program-utilization-on-patient-activation-measure-scores-among-patients-with-rheumatoid-arthritis\/","journal-title":"Arthritis Rheumatol"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-015-0256-7"},{"key":"e_1_3_3_88_1","doi-asserted-by":"crossref","unstructured":"Vermeire S D'Heygere F Nakad A et al. (2018). Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study. Patient Prefer Adherence 12:1193\u2013202.","DOI":"10.2147\/PPA.S154181"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920101506140910150612"}],"container-title":["Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10717544.2019.1587043","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10717544.2019.1587043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T19:55:16Z","timestamp":1770926116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10717544.2019.1587043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1080\/10717544.2019.1587043"],"URL":"https:\/\/doi.org\/10.1080\/10717544.2019.1587043","relation":{},"ISSN":["1071-7544","1521-0464"],"issn-type":[{"value":"1071-7544","type":"print"},{"value":"1521-0464","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idrd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idrd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-12-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}